National Institute on Drug Abuse Awards Gene Logic $6 Million Contract For Preclinical Studies of Medications to Treat Drug Addiction | GenomeWeb

NEW YORK, Oct. 8 (GenomeWeb News) - Gene Logic announced today that it will receive up to $6 million over the next four years from the National Institute on Drug Abuse to provide preclinical safety and pharmacology studies focused on developing safe and effective medications for the treatment of drug addiction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.